✦ LIBER ✦

DPC 817 boosts background therapy in HIV infections

✍ Scribed by Sullivan, S

Book ID: 120852590
Publisher: Adis International Limited (now part of Wolters Kluwer Health)
Year: 2005
Weight: 196 KB
Volume: &NA;
Category: Article
ISSN: 1173-8324
DOI: 10.2165/00128413-200515030-00016

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

DPC 817 effective in HIV-1 infection

📂 Article 📅 2003 🏛 Adis International Limited (now part of Wolters Kl ⚖ 152 KB

DPC 817 development discontinued due to

DPC 817 development discontinued due to hyperlipasaemia in patients with HIV

📂 Article 📅 2006 🏛 Adis International Limited (now part of Wolters Kl ⚖ 133 KB

Raltegravir with Optimized Background Th

Raltegravir with Optimized Background Therapy for Resistant HIV-1 Infection

✍ Steigbigel, Roy T.; Cooper, David A.; Kumar, Princy N.; Eron, Joseph E.; Schecht 📂 Article 📅 2008 🏛 Massachusetts Medical Society 🌐 English ⚖ 324 KB

Hyperbilirubinemia during therapy with a

Hyperbilirubinemia during therapy with atazanavir boosted with ritonavir in HIV-infected patients in Lodz region

✍ Kamila Wójcik; Elżbieta Jabłonowska 📂 Article 📅 2012 🏛 Termedia Sp. z.o.o. 🌐 English ⚖ 113 KB

Advances in HIV-infection therapy

✍ C.E. Orfanos; R. Husak 📂 Article 📅 1998 🏛 John Wiley and Sons 🌐 English ⚖ 124 KB

Combination therapy in primary HIV infec

Combination therapy in primary HIV infection

✍ L. Perrin; B. Hirschel 📂 Article 📅 1996 🏛 Elsevier Science 🌐 English ⚖ 210 KB